【レポートの概要（一部）】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY DISEASE
• Market segmentation by disease
• Comparison by disease
• HSC syndrome – Market size and forecast 2018-2023
• CNS syndrome – Market size and forecast 2018-2023
• GI syndrome – Market size and forecast 2018-2023
• Cardiovascular syndrome – Market size and forecast 2018-2023
• Market opportunity by disease
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• Americas – Market size and forecast 2018-2023
• EMEA – Market size and forecast 2018-2023
• APAC – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Amgen
• Neumedicines
• Onconova Therapeutics
• Partner Therapeutics
• Tonix Pharmaceuticals
PART 14: APPENDIX
• Research methodology
• List of abbreviations
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: Disease – Market share 2018-2023 (%)
Exhibit 18: Comparison by disease
Exhibit 19: HSC syndrome – Market size and forecast 2018-2023 ($ millions)
Exhibit 20: HSC syndrome – Year-over-year growth 2019-2023 (%)
Exhibit 21: CNS syndrome – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: CNS syndrome – Year-over-year growth 2019-2023 (%)
Exhibit 23: GI syndrome – Market size and forecast 2018-2023 ($ millions)
Exhibit 24: GI syndrome – Year-over-year growth 2019-2023 (%)
Exhibit 25: Cardiovascular syndrome – Market size and forecast 2018-2023 ($ millions)
Exhibit 26: Cardiovascular syndrome – Year-over-year growth 2019-2023 (%)
Exhibit 27: Market opportunity by disease
Exhibit 28: Customer landscape
Exhibit 29: Market share by geography 2018-2023 (%)
Exhibit 30: Geographic comparison
Exhibit 31: Americas – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Americas – Year-over-year growth 2019-2023 (%)
Exhibit 33: EMEA – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: EMEA – Year-over-year growth 2019-2023 (%)
Exhibit 35: APAC – Market size and forecast 2018-2023 ($ millions)
Exhibit 36: APAC – Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Amgen – Vendor overview
Exhibit 46: Amgen – Business segments
Exhibit 47: Amgen – Organizational developments
Exhibit 48: Amgen – Geographic focus
Exhibit 49: Amgen – Segment focus
Exhibit 50: Amgen – Key offerings
Exhibit 51: Amgen – Key customers
Exhibit 52: Neumedicines – Vendor overview
Exhibit 53: Neumedicines – Business segments
Exhibit 54: Neumedicines – Organizational developments
Exhibit 55: Neumedicines – Segment focus
Exhibit 56: Neumedicines – Key offerings
Exhibit 57: Neumedicines – Key customers
Exhibit 58: Onconova Therapeutics – Vendor overview
Exhibit 59: Onconova Therapeutics – Business segments
Exhibit 60: Onconova Therapeutics – Organizational developments
Exhibit 61: Onconova Therapeutics – Segment focus
Exhibit 62: Onconova Therapeutics – Key offerings
Exhibit 63: Onconova Therapeutics – Key customers
Exhibit 64: Partner Therapeutics – Vendor overview
Exhibit 65: Partner Therapeutics – Business segments
Exhibit 66: Partner Therapeutics – Organizational developments
Exhibit 67: Partner Therapeutics – Segment focus
Exhibit 68: Partner Therapeutics – Key offerings
Exhibit 69: Partner Therapeutics – Key customers
Exhibit 70: Tonix Pharmaceuticals – Vendor overview
Exhibit 71: Tonix Pharmaceuticals – Business segments
Exhibit 72: Tonix Pharmaceuticals – Organizational developments
Exhibit 73: Tonix Pharmaceuticals – Segment focus
Exhibit 74: Tonix Pharmaceuticals – Key offerings
Exhibit 75: Tonix Pharmaceuticals – Key customers
Exhibit 76: List of abbreviations Error! Bookmark not defined.
【レポート販売概要】
■ タイトル：放射線症候群治療の世界市場2019-2023■ 英文：Global Radiation Syndrome Treatment Market 2019-2023
■ 発行日：2018年11月8日
■ 調査会社：Technavio
■ 商品コード：IRTNTR30225
■ 調査対象地域：グローバル、アジア、北米、ヨーロッパ（EMEA）
- 手術廃棄物管理の世界市場2017-2021About Surgical Waste Management Waste that is generated during surgical processes is known as surgical waste. Surgical waste is both hazardous and non-hazardous. Out of the waste generated from surgeries, 85% is non-hazardous and 15% is hazardous. Surgical waste is a huge threat to the environment. Hence, it necessitates proper disposal. Annually, around 250 million surgeries are carried out acros …
- 抗生物質の世界市場：画期的医薬品の市場機会及び商用化Frontier Pharma: Antibiotics - Identifying and Commercializing First-in-Class Innovation Summary An Extensive Developmental Pipeline, but Limited First in Class Innovation The antibiotics pipeline is very active, with 741 products in development. Of these, the majority (85%) are at the Discovery or Preclinical stages and have not yet entered human trials. Such a high proportion of drugs at the ear …
- 抗凝固療法の米国市場予測（～2022年）“The US anticoagulation therapy market projected to grow at a CAGR of 8.5%.”The US anticoagulation therapy market is projected to reach USD 27.83 billion by 2022 from an estimated USD 18.49 billion in 2017, at a CAGR of 8.5%. The US anticoagulation therapy market is segmented into products (anticoagulation drugs, PT/INR testing devices) and anticoagulation clinics. The growth of the anticoagulatio …
- 電池管理システムの世界市場分析：電池タイプ別（リチウムイオンベース、鉛酸ベース、ニッケルベース、流動電池）、位相別（集中型、分散型、モジュール式）、用途別、セグメント予測、2014-2025The global Battery Management System (BMS) market size is anticipated to reach USD 11.17 billion by 2025, according to a new report by Grand View Research, Inc. The growing trend of renewable energy generation was driven by the increasing concerns of climate change across the globe. Additionally, the decreasing prices of solar photovoltaic cells, favorable government incentives, and the declining …
- 石油・ガス産業におけるインダストリアルIoT(IIoT)センサーの世界市場2018-2022About IIoT Sensors in Oil and Gas Industry IIoT sensors are devices that can communicate/deliver their readings to internet cloud services for further aggregation and analysis of trends within an industrial setting. Technavio’s analysts forecast the global IIoT sensors market in oil and gas industry to grow at a CAGR of 5.39% during the period 2018-2022. Covered in this report The report covers th …
- Kinder Morgan Energy Partners, L.P.社の石油・ガス開発・生産動向及びコスト分析（2013年）Kinder Morgan Energy Partners, L.P. Oil & Gas Exploration and Production Operations and Cost Analysis - 2013 Summary Kinder Morgan Energy Partners, L.P. (KMP) is a pipeline transportation and energy storage company. KMP's pipelines transport natural gas, crude oil, refined petroleum products, condensate, CO2 and other associated products, and the company's terminals store petroleum products, ethan …
- 高視認性服の世界市場2016-2020About High-Visibility Clothing High-visibility clothing, a sub-segment of protective clothing in the personal protective equipment (PPE) industry, is worn to alert vehicle operators and drivers of the presence of the worker in low-light or poor-visibility environment. High-visibility clothing is compulsory when the workers are working around moving vehicles like cars, trucks, or other machinery li …
- 実験室装置サービスの世界市場予測（～2021年）：修理、較正、検証The global laboratory equipment services market, in terms of value, is projected to reach USD 11.51 Billion by 2021 from USD 6.50 Billion in 2016, at a CAGR of 10.0% during the forecast period. This market is expected to grow faster in terms of volume than value. Growth in this market is mainly driven by increasing research in pharmaceutical and biotechnology industries and the growing need for ti …
- Albaconazole (Dermatophytic Onychomycosis)：市場予測と分析（～2022）Albaconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Albaconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022”. Dermatophytic onychomycosis (DO) is characterized as being a fungal infection of the nail. Infection can involve the nail unit (nail matrix, nail bed, or nai …
- PD-1・PD-L1阻害剤の世界市場2019-2023About this market Special drug designations to drive the market growth. One of the major benefits that some of the PD-1 and PD-L1 inhibitors have is the special drug designations given by the regulatory bodies. Many of these drugs have received designations such as breakthrough designation and fast track designation from the US FDA. the EMA. and other regulatory bodies. Vendors who have received t …
- 分子診断の世界市場2016-2020About Molecular Diagnostics The traditional trial and error techniques that were used in the field of medicine are now being replaced by accurate, safe, marker-assisted, molecular-guided treatments. Molecular diagnostics is one such technique. This is a technique that involves measurement and analysis of DNA and RNA at the molecular level to detect changes in biochemical pathways. The aim of perfo …
- リテールバンキング商品のマーケティング戦略：グローバル・ベストプラクティス分析The report discusses key marketing strategies adopted by banks to strengthen their brand values and target diverse customer groups through effective segmentation and product positioning: • It discusses key marketing trends in the retail banking industry in both developed and emerging economies • It highlights key challenges faced by banks in both developed and emerging economies when formulating e …
- 世界のパーソナルクラウド市場Cloud computing which has been making headlines in the tech world has evolved a lot during the 2000’s. ‘Personal Cloud’ is a relatively new concept which offers a truly personalized experience to an individual user using cloud. In today’s digital world, users are keen on storing and managing their personal data via multiple devices, while ensuring secure access to the same. Personal cloud promises …
- 患者登録ソフトウエアの世界市場：集団健康管理、患者ケア管理、ポイント・オブ・ケアThe patient registry software market is expected to reach $610.8 million by 2019 from $381.0 million in 2014, at a CAGR of 9.9%. The global patient registry software market is categorized on the basis of delivery model, product type, database type, functionality, end user, and region. The subscription models segment is expected to register the highest growth rate in the patient registry software m …
- 世界主要国のヘルペス・マーカー検査（医療機器）市場：サプライヤーシェア及び市場予測The report presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Herpes definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for Herpes Simplex I/II and Herpes Type VI testing for the following markets: …
